Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
BS Medicine Episode #623: Less than 140, 130, or 120? Counting down to the optimal systolic blood pressure target
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk








Please provide any additional comments (optional).